Literature DB >> 18481137

A case of refractory Kawasaki disease complicated by peripheral ischemia.

Na Yeon Kim1, Deok Young Choi, Mi Jin Jung, In-Sang Jeon.   

Abstract

Kawasaki disease (KD), an acute systemic vasculitis that primarily affects infants and young children, is occasionally refractory to initial high-dose intravenous immunoglobulin (IVIG). Some patients with KD develop peripheral gangrene as a fatal complication, though this is rare. There has been no case reported in the literature of complicated peripheral gangrene that completely resolved without sequelae. Recently, we encountered a patient with KD which was refractory to IVIG, later developing peripheral gangrene. For the treatment of a peripheral gangrene dexamethasone, methotrexate, and an anticoagulant were administered, resulting in resolution of the gangrenous lesions without sequelae. Early diagnosis and treatment can reduce permanent sequelae and mortality from refractory KD complicated by peripheral ischemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18481137     DOI: 10.1007/s00246-008-9221-4

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  12 in total

1.  The treatment of Kawasaki syndrome with intravenous gamma globulin.

Authors:  J W Newburger; M Takahashi; J C Burns; A S Beiser; K J Chung; C E Duffy; M P Glode; W H Mason; V Reddy; S P Sanders
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

2.  Treatment of intravenous immunoglobulin-resistant Kawasaki disease with methotrexate.

Authors:  S Y Ahn; D S Kim
Journal:  Scand J Rheumatol       Date:  2005 Mar-Apr       Impact factor: 3.641

3.  Peripheral gangrene in adult-onset Kawasaki disease.

Authors:  I Bonté; A Mahr; L Laroche; L Guillevin; M Robineau
Journal:  Scand J Rheumatol       Date:  2005       Impact factor: 3.641

4.  Late intravenous gamma globulin treatment in infants and children with Kawasaki disease and coronary artery abnormalities.

Authors:  M Marasini; G Pongiglione; D Gazzolo; A Campelli; D Ribaldone; S Caponnetto
Journal:  Am J Cardiol       Date:  1991-09-15       Impact factor: 2.778

5.  Infantile Kawasaki disease and peripheral gangrene.

Authors:  Amy L Durall; John R Phillips; Martin E Weisse; Charles J Mullett
Journal:  J Pediatr       Date:  2006-07       Impact factor: 4.406

6.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Pediatrics       Date:  2004-12       Impact factor: 7.124

Review 7.  Kawasaki disease complicated by peripheral gangrene.

Authors:  J S Chang; J S Lin; C T Peng; C H Tsai
Journal:  Pediatr Cardiol       Date:  1999 Mar-Apr       Impact factor: 1.655

8.  A case of intravenous immunoglobulin-resistant Kawasaki disease treated with methotrexate.

Authors:  Mi Seon Lee; Seon Young An; Gwang Cheon Jang; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2002-08       Impact factor: 2.759

9.  Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients.

Authors:  H Kato; T Sugimura; T Akagi; N Sato; K Hashino; Y Maeno; T Kazue; G Eto; R Yamakawa
Journal:  Circulation       Date:  1996-09-15       Impact factor: 29.690

10.  Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids.

Authors:  D A Wright; J W Newburger; A Baker; R P Sundel
Journal:  J Pediatr       Date:  1996-01       Impact factor: 4.406

View more
  5 in total

Review 1.  Kawasaki disease: etiopathogenesis and novel treatment strategies.

Authors:  Shreya Agarwal; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2016-09-13       Impact factor: 4.473

2.  Predicting factors for refractory kawasaki disease.

Authors:  Young-Sun Do; Ki-Won Kim; Jin-Kyong Chun; Byung Ho Cha; Mee Kyung Namgoong; Hae Yong Lee
Journal:  Korean Circ J       Date:  2010-05-27       Impact factor: 3.243

3.  Peripheral Gangerene, an Unusual Presentation of Infantile Kawasaki: A Case Report and Literature Review.

Authors:  Fatemeh Tahghighi; Maryam Bakhtiari Koohsorkhi; Vahid Ziaee
Journal:  Case Rep Rheumatol       Date:  2021-04-13

Review 4.  Kawasaki disease complicated by peripheral artery thrombosis: a case report and literature review.

Authors:  Nanjun Zhang; Li Yu; Zhongxian Xiong; Yimin Hua; Hongyu Duan; Lina Qiao; Kaiyu Zhou; Chuan Wang
Journal:  Pediatr Rheumatol Online J       Date:  2022-09-05       Impact factor: 3.413

5.  Kawasaki Disease and Peripheral Gangrene in Infancy.

Authors:  Iran Malekzadeh; Vahid Ziaee; Taravat Sadrosadat; Mohammad-Hassan Moardinejad; Keyhan Sayadpour-Zanjani
Journal:  Iran J Pediatr       Date:  2015-12-23       Impact factor: 0.364

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.